(marketscreener.com) The Camargo Blog has published a four-part blog series highlighting those designation programs available specifically for products with rare disease indications. This final installment will explain the criteria, timeline, and benefits of Humanitarian Use Device designation. The HUD designation program is...https://www.marketscreener.com/news/latest/FDA-Designations-for-Rare-Disease-Products-Part-4-Humanitarian-Use-Device--33307379/?utm_medium=RSS&utm_content=20210520
Camargo is an Ohio-based consulting firm that provides drug development strategy, regulatory support, protocol development and related services to biopharmaceutical companies.